rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2002-9-6
|
pubmed:abstractText |
Alterations of expression of the cytoskeletal proteins Gelsolin and E-cadherin have been implicated in urothelial carcinoma tumorigenesis. However, it is not clear how these altered expressions associate with tumor progression, nor is it clear how these protein markers provide prognostic value for urothelial carcinomas.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0008-543X
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2002 American Cancer Society.
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
95
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1247-57
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:12216092-Adult,
pubmed-meshheading:12216092-Aged,
pubmed-meshheading:12216092-Aged, 80 and over,
pubmed-meshheading:12216092-Cadherins,
pubmed-meshheading:12216092-Carcinoma, Transitional Cell,
pubmed-meshheading:12216092-Female,
pubmed-meshheading:12216092-Gelsolin,
pubmed-meshheading:12216092-Humans,
pubmed-meshheading:12216092-Immunohistochemistry,
pubmed-meshheading:12216092-Ki-67 Antigen,
pubmed-meshheading:12216092-Male,
pubmed-meshheading:12216092-Middle Aged,
pubmed-meshheading:12216092-Precancerous Conditions,
pubmed-meshheading:12216092-Prognosis,
pubmed-meshheading:12216092-Tumor Markers, Biological,
pubmed-meshheading:12216092-Tumor Suppressor Protein p53,
pubmed-meshheading:12216092-Urinary Bladder Neoplasms
|
pubmed:year |
2002
|
pubmed:articleTitle |
Tissue microarray analysis of cytoskeletal actin-associated biomarkers gelsolin and E-cadherin in urothelial carcinoma.
|
pubmed:affiliation |
Department of Pathology and Laboratory Medicine, University of California at Los Angeles, 90095, USA. jrao@mednet.ucla.edu
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|